Epetirimod

CAS No. 227318-71-0

Epetirimod( —— )

Catalog No. M34589 CAS No. 227318-71-0

Epetirimod (S-30563) is a small molecule immunomodulator with antitumor and anti-infective activity for the study of papillomavirus infections.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 445 In Stock
5MG 504 In Stock
10MG 728 In Stock
25MG 1121 In Stock
50MG 1479 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Epetirimod
  • Note
    Research use only, not for human use.
  • Brief Description
    Epetirimod (S-30563) is a small molecule immunomodulator with antitumor and anti-infective activity for the study of papillomavirus infections.
  • Description
    Epetirimod (S-30563) is a small molecule immunomodulator with antitumor and anti-infective activity for the study of papillomavirus infections.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    Antiviral
  • Recptor
    Antiviral
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    227318-71-0
  • Formula Weight
    241.29
  • Molecular Formula
    C13H15N5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C(C)C)N1C=2C=3C(N=C(N)C2N=C1)=CC=CN3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • WIN 54954

    WIN 54954 is an orally available antiviral agent that inhibits Coxsackievirus and inhibits viral translation or transcription.

  • Ezurpimtrostat hydro...

    Ezurpimtrostat hydrochloride (GNS561 hydrochloride) is an orally available palmitoyl protein thioesterase-1 inhibitor with antifibrotic, antiviral, and anticancer effects that blocks cancer cell proliferation by interacting with palmitoyl protein thioesterase to inhibit late autophagy and dose-dependently increase lysosomal accumulation.

  • ERDRP-0519

    ERDRP-0519 is an orally bioavailable small-molecule inhibitor of the Measles virus (MeV) polymerase.